The Effect of Mask Design on Ventilation Parameters in COPD and OHS Patients on Long-term Home Non-invasive Ventilation. An Experimental Study.

NCT ID: NCT06972589

Last Updated: 2025-05-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-31

Study Completion Date

2026-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Chronic obstructive pulmonary disease (COPD) and obesity hypoventilation syndrome (OHS) are respiratory conditions that disrupt normal breathing. Positive airway pressure, specifically Non-Invasive Ventilation (NIV) delivers positive pressures via an interface such as a face mask and has been shown to improve breathing and reduce symptoms in patients with these conditions. Regular use of NIV can lead to better symptom management, improved quality of life, and reduced use of healthcare resources. However, poor performance of the NIV mask and poor comfort can make NIV therapy harder to tolerate. This study will assess if a new mask helps to improve the breathing of people on NIV and normalize blood gases.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants are moved to the sleep laboratory for the night where they are provided with beds.

* The participants are put on their prescribed airway pressure support with the first randomized mask.
* After at least 60 minutes of recording, participants are awakened to switch back to the second mask. They are then allowed to sleep uninterrupted for the rest of the night.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COPD (Chronic Obstructive Pulmonary Disease) Obesity Hypoventilation Syndrome (OHS)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Noninvasive ventilation (CPAP or bilevel) with the investigational mask

Group Type EXPERIMENTAL

Investigational Mask

Intervention Type DEVICE

Wear mask to enable the delivery of noninvasive ventilation (CPAP or bilevel) therapy during sleep.

Noninvasive ventilation (CPAP or bilevel) with the conventional mask

Group Type ACTIVE_COMPARATOR

Conventional mask

Intervention Type DEVICE

Wear mask to enable the delivery of noninvasive ventilation (CPAP or bilevel) therapy during sleep.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Investigational Mask

Wear mask to enable the delivery of noninvasive ventilation (CPAP or bilevel) therapy during sleep.

Intervention Type DEVICE

Conventional mask

Wear mask to enable the delivery of noninvasive ventilation (CPAP or bilevel) therapy during sleep.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age over 18 years
* Prescribed nocturnal NIV for COPD or OHS
* Able to complete an overnight sleep study
* Comfortable to sleep on a standard double bed
* Capacity to complete informed consent

Exclusion Criteria

* Uncontrolled sleep apnea (Apnea-hypopnea index (AHI) over 15 events/hour off personal NIV device data)
* Prescribed IPAP above 25 cmH2O
* Allergic to adhesive of the sensors
* Self-reported cold/flu symptoms
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fisher and Paykel Healthcare

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

William Good, Medical degree

Role: PRINCIPAL_INVESTIGATOR

Middlemore Hospital, New Zealand

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fisher and Paykel Healthcare Sleep Laboratory

Auckland, , New Zealand

Site Status

Countries

Review the countries where the study has at least one active or historical site.

New Zealand

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Valeria Mereacre, PhD Physiology

Role: CONTACT

02102819036

Jessica Fogarin

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jessica Fogarin

Role: primary

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CIA-356

Identifier Type: OTHER

Identifier Source: secondary_id

U1111-1322-0270

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.